Join the club for FREE to access the whole archive and other member benefits.

FDA

Ensuring safety of drugs, medical supplies and food which is used daily.

FDA is an agency within the Department of Health and Human Services.

The FDA's organization consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods, Global Regulatory Operations and Policy, and Operations.

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.

The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.

Visit website: https://www.fda.gov/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

FDA Blog Posts

Genflow Seeks Investors for Novel SIRT6 DNA Repair Anti-Ageing Therapy
16-Jul-2020 Great to see a startup willing to explicitly state they are treating ageing itself as a disease

Ambrosia Plasma relaunches - announces improvement in key ageing biomarkers
03-Feb-2020 The Club interviews Jesse Karmazin, CEO, to find out more about the trial, the FDA warning, and the relaunch

Does no smoking mean no vaping?
19-Aug-2019 Sometimes news coverage of e-cigarettes can be confusing - what's the best advice?

People at FDA

Company Representative

Director of the Center for Devices and Radiological Health at the FDA.

Academic

Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration

Academic

American physician and investor.

Academic

Dr. A. Abernethy is a Principal Deputy Commissioner and Acting CIO at US FDA

FDA News

FDA warns robotic surgery for breast cancer is unproven and could pose health risks

pharmaphorum - 22-Aug-2021

Prior study approval and monitoring long-term outcomes are needed to ensure patient's safety

Read more...

Lifespan.io interviews George Church about gene therapy and longevity

Lifespan.io (LEAF) - 28-Jul-2021

Discusses animal trials, potential human trials, reeducating the FDA and improvements in technology

Read more...

For the first time in 20 years, FDA approved new drug to treat Alzheimer's disease

BBC - 08-Jun-2021

A long way from a cure, but hopefully indicates that Alzheimer's isn't unassailable

Read more...

Bayshore latest drug maker to recall metformin after carcinogens found

FiercePharma - 21-Aug-2020

A good example of why you have to be careful buying meds - even big pharma has problems.

Read more...

Brain ageing reversed by Israeli doctor through an oxygen chamber

The times of Israel - 15-Jul-2020

Don't try this at home! Too much oxygen (hyperoxia) is definitely bad for you

Read more...

Dermal patches by 4D-bioprinting to the rescue!

3DPrint.com - 29-Jun-2020

Technology to treat diabetic foot ulcerations will be commercially available in a year

Read more...

Crowdsourced samples of metformin from USA contain unacceptable levels of NDMA

New York Times - 27-May-2020

Found only in extended-release versions of metformin, immediate-release versions are okay

Read more...

Parkinson's patient can swim again after stem cell transplant

Newsweek - 14-May-2020

Study and procedure represent a milestone in personalized medicine for Parkinson's

Read more...

The integral role of gut microbiome in precision medicine

AACC (American Association for Clinical Chemistry) - 01-May-2020

Huge potential in a more personalized diagnostics and diet-based disease interventions

Read more...

Mojo Vision secures another $51M to develop its augmented reality contact lens

TechCrunch - 29-Apr-2020

BBC was blown away at CES so let's hope this helps bring this "iPhone of wearables" to market

Read more...

Longevity Vision Fund joins Series B funding for Sigilon Therapeutics

Longevity Vision Fund - 20-Apr-2020

To support human clinical trial of novel encapsulated cell therapy for hemophilia A

Read more...

FDA gives the green light for human trials against a new coronavirus therapy

WebMD - 03-Apr-2020

May cause serious adverse effects if stem cells over attack normal lung cells

Read more...

COVID-19 advanced testing lab created by UC Berkeley scientists

University of California, Berkeley - 30-Mar-2020

In response to mass testing needs, they employ robotics and automation for accuracy and speed

Read more...

Digital twins to revolutionize personalized medicine

Medical Futurist - 19-Mar-2020

Risk prediction and best therapy for a specific patient is a future possibility

Read more...

Comprehensive history and explanation of senescent cells

The Scientist - 01-Mar-2020

Including the latest on clinical trials of first-generation senolytics

Read more...

New, more reliable FDA-approved device to help type 1 diabetes patients

The Verge - 13-Dec-2019

This closed-loop system customizes treatment, automatically adjusts insulin levels

Read more...

FDA alerts consumers about the CBD products

Washington Post - 28-Nov-2019

CBD products developing companies are frustrated with the FDA's lack of of clear regulations

Read more...

Revitalizing the aged brain - research evidence in animal models

Fight Aging! - 08-Oct-2019

Will this increase the tendency towards young blood transfusion?

Read more...

Rapamycin shows a sixty percent life expectancy increase in mice model

Aging - 04-Oct-2019

Detailed history and review of current understanding of Rapamycin and longevity

Read more...

New drugs can be unsafe leading to recalls

Harvard Health Publishing - 02-May-2019

The high rate of alerts and warnings maybe the result of post-approval monitoring

Read more...

Display all news